Albuterol Sulfate Inhalation Solution
Labelling: Illegible label
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Presence of Foreign Substance; presence of black particles describes generically as cellulose-based bundles of brown fibrous material.
Cause type: Particulate / foreign matter
Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.
Albuterol Sulfate Syrup, 2 mg/ 5 mL, 473 mL bottle, Rx only, Manufactured in Canada by Contract Pharmaceuticals Limited, Canada, Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA --- NDC 0093-0661-16
Compare with the code on your package — it is the most precise check available.
Drug: Albuterol
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Labelling: Illegible label
Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.
Defective delivery system
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).
Failed Impurities/Degradation Specifications.
Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.
Superpotent drug: Out of specification test result for assay during stability testing.
CGMP Deviations
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.